Jazz Pharmaceuticals to Present at 2010 J.P. Morgan Healthcare Conference

Jan 07, 2010, 19:59 ET from Jazz Pharmaceuticals, Inc.

PALO ALTO, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that Bruce Cozadd, Chairman and CEO, will present a corporate overview, discuss financial results, and provide 2010 guidance at the 28th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2010 at 11:00 a.m. PST at The Westin St. Francis in San Francisco.

A webcast of the presentation may be accessed by visiting http://metameetings.com/webcasts/jpmorgan/healthcare10/directlink?ticker=JAZZ, and after the presentation, the slides may be accessed by visiting the Investors section of the Jazz Pharmaceuticals website at http://www.JazzPharmaceuticals.com. The webcast and the slides will be available for two weeks following the presentation.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments for important, underserved markets in neurology and psychiatry. For further information please see www.jazzpharmaceuticals.com.

SOURCE Jazz Pharmaceuticals, Inc.



RELATED LINKS

http://www.JazzPharmaceuticals.com